Evidence map›Paper›PMID 18421281›Full record

Trial reportObesity (Silver Spring, Md.)2008

Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.

D Enette Larson-Meyer, Bradley R Newcomer, Leonie K Heilbronn, Julia Volaufova, Steven R Smith, Anthony J Alfonso, Michael Lefevre, Jennifer C Rood, Donald A Williamson, Eric Ravussin and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Obesity (Silver Spring, Md.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 7 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 7 syntheses or guidelines pooled it, 215 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Intermittent fasting for the prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2021
    Pooled it
  6. ESPEN guideline on clinical nutrition in liver disease.Clinical nutrition (Edinburgh, Scotland) · 2019
    Guideline
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Comprehensive lifestyle interventionWorld journal of gastroenterology · 2019
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

D Enette Larson-MeyerPennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA. enette@uwyo.edu
Bradley R Newcomer
Leonie K Heilbronn
Julia Volaufova
Steven R Smith
Anthony J Alfonso
Michael Lefevre
Jennifer C Rood
Donald A Williamson
Eric Ravussin
Pennington CALERIE Team
Louisiana State University · USPennington Biomedical Research Center · USGarvan Institute of Medical Research · AULouisiana State University Health Sciences Center New Orleans · USUniversity of Alabama at Birmingham · USUniversity of Wyoming · US

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leanne Maree Redman · 2005 to 2026
$26.5M
Metabolic Adaptations to Two Year Caloric RestrictionU01AG020478 · NIA · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RAVUSSIN, ERIC · 2002 to 2008
$13.4M
Diet/Intramyocellular Lipid/Endurance PerformanceK01DK062018 · NIDDK · UNIVERSITY OF WYOMING · PI LARSON-MEYER, D ENETTE · 2003 to 2005
$271k
NIA NIH HHS U01 AG020478NIA NIH HHS U01 AG20478NIDDK NIH HHS K01 DK062018NIDDK NIH HHS P30 DK072476
6 · The paper itself

Abstract

objectiveNonalcoholic fatty liver disease (NAFLD) and its association with insulin resistance are increasingly recognized as major health burdens. The main objectives of this study were to assess the relation between liver lipid content and serum lipids, markers of liver function and inflammation in healthy overweight subjects, and to determine whether caloric restriction (CR) (which improves insulin resistance) reduces liver lipids in association with these same measures. METHODS AND PROCEDURES: Forty-six white and black overweight men and women (BMI = 24.7-31.3 kg/m(2)) were randomized to "control (CO)" = 100% energy requirements; "CR" = 25%; "caloric restriction and increased structured exercise (CR+EX)"= 12.5% CR + 12.5% increase in energy expenditure through exercise; or "low-calorie diet (LCD)" = 15% weight loss by liquid diet followed by weight-maintenance, for 6 months. Liver lipid content was assessed by magnetic resonance spectroscopy (MRS) and computed tomography (CT). Lipid concentrations, markers of liver function (alanine aminotransferase (ALT), alkaline phosphatase (ALK)), and whole-body inflammation (tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hsCRP)) were measured in fasting blood.

resultsAt baseline, increased liver lipid content (by MRS) correlated (P < 0.05) with elevated fasting triglyceride (r = 0.52), ALT (r = 0.42), and hsCRP (r = 0.33) concentrations after adjusting for sex, race, and alcohol consumption. With CR, liver lipid content was significantly lowered by CR, CR+EX, and LCD (detected by MRS only). The reduction in liver lipid content, however, was not significantly correlated with the reduction in triglycerides (r = 0.26; P = 0.11) or with the changes in ALT, high-density lipoprotein (HDL)-cholesterol, or markers of whole-body inflammation. DISCUSSION: CR may be beneficial for reducing liver lipid and lowering triglycerides in overweight subjects without known NAFLD.

Indexed as

Caloric RestrictionAdultAlanine TransaminaseAlkaline PhosphataseCholesterol, HDLCombined Modality TherapyC-Reactive ProteinCross-Sectional StudiesExerciseFemaleHumansInflammationInsulin ResistanceInterleukin-6LipidsLiverAlanine TransaminaseAlkaline PhosphataseCholesterol, HDLC-Reactive ProteinInterleukin-6LipidsTriglyceridesTumor Necrosis Factor-alpha

Identifiers

PMID18421281
PMCPMC2748341
OpenAlexW2088769174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.